14,825 Views
•
12:40 min
December 07, 2014
DOI:
10.3791/51984-v
キナーゼ阻害剤治療に対する遺伝的抵抗性の出現は、効果的な癌治療のための重要な課題を提起する。新たに開発された薬剤に対して耐性変異の同定および特徴は、より良い臨床管理、次世代薬剤設計に役立ちます。ここでは、in vitroスクリーニングおよび耐性変異の検証のために私たちのプロトコルを記述します。
09:38
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
関連ビデオ
8744 Views
07:42
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
7893 Views
10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
8204 Views
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
5955 Views
13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
7809 Views
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
18084 Views
14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
3142 Views
09:33
Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
1053 Views
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
14.8K Views
8.2K Views
Read Article
Cite this Article
Kesarwani, M., Huber, E., Kincaid, Z., Azam, M. A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors. J. Vis. Exp. (94), e51984, doi:10.3791/51984 (2014).
Download .ris file
Copy
Share Video
.